Medicare Expands Access for Weight Loss Drugs to Some Beneficiaries

Why it matters locally: The expansion of Medicare coverage for GLP-1 weight loss medications will directly impact the significant number of Medicare beneficiaries in Mississippi, potentially improving health outcomes for those struggling with obesity and related conditions.

The utilization of GLP-1 medications for weight loss has shown an increase among American adults. A new Gallup poll indicates that 11% of adults currently use one of these drugs. This represents a significant rise from two years prior, when 3% of adults reported using them. Medicare has now made it possible for some patients to obtain these medications. William Brangham discussed these developments with Juliette Cubanski.